Biolitec is making news!

We invite you to check back frequently for updated press coverage.  For additional information, please visit About biolitec. To receive news and announcements by email sign-up for our e-Newsletter.


17.05.2008 FASTEST MINIMALLY-INVASIVE IN-OFFICE LASER TREATMENT FOR BPH [more]
14.03.2008 biolitec has entered into a non-binding letter of intent for the acquisition of specified assets of Diomed Holdings, Inc. [more]
11.03.2008 biolitec 1470nm Laser Cleared for Vein Surgery [more]
28.02.2008 David S. Turk, MD, Wins 2007 Thirlby Award for In-Office Laser Vaporization of Prostate [more]
15.01.2008 biolitec’s amendments requested for the extension of sales and marketing of Foscan® have been approved – “Low dose” vials to be used for clinical trials in dermatology and cholangiocarcinoma [more]
20.12.2007 Analysts recommend biolitec stock: Fair value is over 20 Euros [more]
17.12.2007 Innovation in Cologne Clinic: Treatment of the widespread male disease of "enlarged prostate" using the new BPH laser [more]
30.11.2007 biolitec AG doubles EBIT to €1.7M - sales in first quarter of 2007/2008 increase by 26% to €9.3M - cash increase in share capital successfully concluded [more]
27.11.2007 biolitec’s new ELVeS™ PainLess laser allows a low pain treatment procedure to remove varicose veins [more]
27.11.2007 biolitec making significant expansion progress in the US BPH market - 40% market share expected for the end of 2008 [more]
08.11.2007 Biolitec signs distribution contract and term sheet for cancer drug Foscan® with major leading pharmaceutical companies in Latin America and Italy [more]
28.09.2007 biolitec AG – Record profit in FY 2006/07 with a growth of 191% to Euro 6,7 million [more]
26.09.2007 biolitec AG is introducing the LIFE BPH laser at the most important German urological conference in Berlin [more]
19.09.2007 Free State of Thuringia sponsors a forward-looking project by biolitec that treats venous insufficiency with temoporfin foam [more]
06.09.2007 biolitec receives FDA approval in the USA for 150-watt BPH laser used for prostate therapy. [more]
03.07.2007 biolitec AG receives bulk order amounting to US $ 9.5 million for urology lasers for ambulant BPH treatment [more]
27.06.2007 biolitec notices strong demand for lasers and application sets for the treatment of DCR (watering eyes) in Asia [more]
21.06.2007 biolitec develops new therapy for the reduction of abdominal fat - hope for people suffering from overweight to minimise visceral fat [more]
31.05.2007 biolitec - earnings more than tripled to cumulated 3.7 million in the third quarter - revenue growth in the USA increased to + 83% [more]
25.05.2007 Strong demand for biolitec’s laser for the treatment of benign prostate hyperplasia in the USA [more]
14.05.2007 biolitec’s Foscan ® is used in a clinical study for the treatment of localised carcinoma of the prostate [more]
27.04.2007 biolitec requests an immediate approvability meeting with the FDA for Foscan® in the US-market [more]
23.04.2007 biolitec AG - study confirms very good results for cancer drug Foscan ® [more]
01.02.2007 biolitec AG commences contract negotiations with US biotech companies on out-licensing and clinical development of its cancer drug Foscan® [more]
18.01.2007 Prime Minister Dieter Althaus impressed of biolitecs’ innovative research centre in Jena [more]

Displaying results 1 to 25 out of 31

1

2

Next >